Qi Chao

USPTO Granted Patents = 26 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 217(Granted Patents)

Company Filing History:

11 out of 39

Ambit Biosciences Corporation

patents

8 out of 169

Signal Pharmaceuticals, Inc.

Ambit Bioscience Corporation

patent

6. 1 out of 1

Estryx Pharma Limited

patent

7. 1 out of 135

Biomarin Pharmaceutical Inc.

patents

Years Active: 2002-2022

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11384055 - Glycolate oxidase inhibitors for the treatment of disease (2022-07-12),

2. 10053430 - RAF kinase modulator compounds and methods of use thereof (2018-08-21),

3. 9975880 - Imidazolidine-2,4-dione dervatives (2018-05-22),

4. 9730937 - RAF kinase modulator compounds and methods of use thereof (2017-08-15),

5. 9682941 - Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase (2017-06-20),

6. 9676752 - Imidazolidine-2,4-dione derivatives (2017-06-13),

7. 9320739 - RAF kinase modulator compounds and methods of use thereof (2016-04-26),

8. 9308207 - JAK kinase modulating compounds and methods of use thereof (2016-04-12),

9. 8969587 - RAF kinase modulator compounds and methods of use thereof (2015-03-03),

10. 8927711 - JAK kinase modulating compounds and methods of use thereof (2015-01-06),

11. 8921546 - Imidazolothiazole compounds for the treatment of disease (2014-12-30),

12. 8618289 - RAF kinase modulator compounds and methods of use thereof (2013-12-31),

13. 8557810 - Imidazolothiazole compounds for the treatment of disease (2013-10-15),

14. 8349851 - JAK kinase modulating compounds and methods of use thereof (2013-01-08),

15. 8129374 - Method of using imidazolothiazole compounds for the treatment of disease (2012-03-06),

Title: The Innovative Journey of Qi Chao: Pioneering Inventor in San Diego

Introduction

In the realm of inventors, Qi Chao shines as a beacon of innovation and creativity. Hailing from San Diego, CA, Qi Chao has made significant contributions to the world of science and technology with her relentless pursuit of excellence.

Latest Patents

Qi Chao holds an impressive portfolio of 26 patents, with her latest inventions focusing on groundbreaking areas of research. One of her recent patents involves Glycolate oxidase inhibitors for the treatment of diseases associated with glyoxylate metabolism, such as primary hyperoxaluria. Another patent highlights her work on RAF kinase modulator compounds for treating diseases mediated by RAF kinases.

Career Highlights

Qi Chao's esteemed career has seen her collaborate with leading companies in the field of biosciences and pharmaceuticals. She has made invaluable contributions during her tenure at Ambit Biosciences Corporation and Signal Pharmaceuticals, Inc., where her innovative solutions have paved the way for advancements in medical treatments and therapies.

Collaborations

Throughout her career, Qi Chao has had the privilege of collaborating with esteemed professionals in the industry. Notable colleagues include Shripad S Bhagwat and Kelly G Sprankle, who have worked alongside Qi Chao to bring her inventions to life and impact the lives of many.

Conclusion

In conclusion, Qi Chao stands as a shining example of innovation and dedication in the world of inventors. Her groundbreaking patents and collaborative efforts have inspired generations of inventors and entrepreneurs to push the boundaries of science and technology. Qi Chao's contributions continue to make a significant impact in the world of research and development, solidifying her legacy as a pioneering inventor in San Diego and beyond.

This text is generated by artificial intelligence and may not be accurate.